Regions Financial Corp’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Buy
15,096
+450
+3% +$12K ﹤0.01% 658
2026
Q1
$393K Sell
14,646
-137
-0.9% -$4.11K ﹤0.01% 670
2025
Q4
$455K Buy
14,783
+1,976
+15% +$61.6K ﹤0.01% 630
2025
Q3
$393K Buy
12,807
+324
+3% +$7.89K ﹤0.01% 671
2025
Q2
$258K Sell
12,483
-817
-6% -$16.8K ﹤0.01% 754
2025
Q1
$260K Sell
13,300
-1,030
-7% -$21.6K ﹤0.01% 727
2024
Q4
$299K Buy
14,330
+930
+7% +$20.4K ﹤0.01% 698
2024
Q3
$327K Buy
13,400
+1,477
+12% +$39.5K ﹤0.01% 685
2024
Q2
$300K Sell
11,923
-47
-0.4% -$1.33K ﹤0.01% 684
2024
Q1
$358K Buy
11,970
+2,670
+29% +$78.4K ﹤0.01% 662
2023
Q4
$296K Buy
9,300
+769
+9% +$24.1K ﹤0.01% 706
2023
Q3
$301K Buy
+8,531
New +$325K ﹤0.01% 680
2020
Q2
Sell
-19,950
Closed -$423K 835
2020
Q1
$423K Buy
19,950
+117
+0.6% +$2.61K 0.01% 523
2019
Q4
$443K Buy
+19,833
New +$433K ﹤0.01% 561

Other funds holding GMAB

Regions Financial Corp's GMAB Position: Q2 2026 in Review

Regions Financial Corp increased its Genmab (GMAB) stake by 3.1% in Q2 2026, buying an estimated $12K and bringing the position to 15,096 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Regions Financial Corp first reported a position in GMAB in Q4 2019 and has held it in 14 quarters since. The position peaked at $455K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Regions Financial Corp held 15,096 shares of Genmab worth $415K as of Q2 2026.
  • Regions Financial Corp bought 450 Genmab shares in Q2 2026, an estimated $12K.
  • Genmab made up ﹤0.01% of Regions Financial Corp's portfolio in Q2 2026, its #658 holding.
  • Regions Financial Corp first reported a position in Genmab in Q4 2019 and has held it in 14 quarters since.
  • Regions Financial Corp's Genmab position peaked at $455K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.